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CLINICAL INVESTIGATION
Stainable aluminum and not aluminum content reflects bone
histology in dialyzed patients
MARIE—CLAUDE FAUGERE and HARTMUT H. MALLUCHE
Division of Nephrology, Bone and Mineral Metabolism, Department of Medicine, University of Kentucky, Lexington, Kentucky, USA
Stainable aluminum and not aluminum content reflects bone histology
in dialyzed patients. Quantitative evaluation of stainable bone aluminum
and measurement of bone aluminum content were done in 55 patients
on chronic maintenance dialysis. All patients underwent bone biopsies.
Histomorphometry of static and dynamic parameters of bone structure,
bone formation and resorption, and quantitation of stainable bone
aluminum at the osteoid—bone interface were performed. In addition,
bone aluminum content was measured by atomic absorption spec-
trophotometry. Bone aluminum content was elevated in all patients (81
9.6 vs. 18 6 gIg dry wt) and stainable aluminum was found in 47%
of them. All patients with predominant low—turnover osteomalacia or
adynamic bone disease displayed stainable bone aluminum. In contrast,
stainable bone aluminum was not present in individuals with predomi-
nant—hyperparathyroid bone disease. Patients with stainable aluminum
had lower bone mass (P < 0.05), higher volume and surface of lamellar
osteoid (P <0.01), less volume and surface of woven osteoid (P < 0.05
and P < 0.01), lower osteoblastic and osteoclastic indices (P < 0.01),
less doubly labelled osteoid seams, lower mineral apposition rate and
lower bone formation rates (P < 0.05 to P < 0.01). Stainable aluminum
correlated with volume of lamellar osteoid and cellular parameters of
bone formation and resorption, mineral apposition rate, and bone
formation rates (P < 0.05 to P < 0.001). In contrast, bone aluminum
content correlated with volume of lamellar osteoid only (F < 0.001).
These findings indicate that stainable aluminum at the mineralization
front and not aluminum content of bone reflects the histopathologic
changes found in bone of dialyzed patients.
It has been established that aluminum might accumulate in
bone and other organs in patients with renal failure [1—8]. Even
though there is controversy as to whether aluminum affects
directly or indirectly bone formation and/or mineralization [9],
it is apparent that aluminum accumulation in bone is associated
with abnormalities in cell function and structure of bone [10,
11]. Aluminum accumulation in bone can be diagnosed by
various methods. Most frequently, total bone aluminum content
is measured by flameless absorption spectrophotometry [12] or
histochemical staining of aluminum in bone is performed. The
latter identifies mainly aluminum deposits at the mineralization
front and at cement lines [13]. The diagnostic value of determi-
nations of total aluminum content in bone versus the histochem-
ical staining with quantitation of aluminum at the mineralization
front for prediction of the histologic changes in bone has not
been established. Therefore, in the current study, bone biopsies
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Fig. 1. Aluminum deposition at the mineralization front. Aluminum is
seen as a dark linear deposit (4.) at the interface between calcified
bone (b) and osteoid (o). Mineralized bone histology. Aurine
tricarboxylic acid stain. Original magnification: 33.4 X.
were done in chronically dialyzed patients, and stainable bone
aluminum as well as total bone aluminum content were mea-
sured. Correlations between histopathologic parameters of
bone and results of the two methods of aluminum determination
were calculated and compared.
Methods
Fifty—five patients on chronic maintenance dialysis were
enrolled in the study. These were patients from two local
centers who were offered to undergo a diagnostic bone biopsy.
There were no selection criteria. All patients who agreed to
undergo a bone biopsy were studied. There were 25 males and
30 females with a mean age of 45 2.2 years (range two to 27
years). Forty—nine patients were on hemodialysis and six pa-
tients on chronic ambulatory peritoneal dialysis. Duration of
dialytic therapy was 45 5 months (range one to 120 months).
The hemodialyzed patients were dialyzed three times weekly,
five hours each, using the Cordis Dow holofiber dialyzer
(Cordis Dow Corp., Miami, Florida, USA) with 1.5 M2 surface
and Travenol AKIO dialysis machines (Travenol Laboratories,
Morton Grove, Illinois, USA). The dialysate contained 3.5 mEq
717
718 Faugere and Malluche
Table 1. Static and dynamic histomorphometric parameters of bone structure, and bone formation and resorption in 55 dialyzed patients with
(sBA) and without (no sBA) stainable aluminum in bone.
Parameters
sBA
N = 26
no sBA
N = 29 P value
Bone structure
Cancellous bone mass 20 1.1 25 1.8 <0.05
Mean trabecular diameter p.m 250 11 274 12 <0.0!
Mean wall thickness p.m 65 t 1.0 74 1.0 <0.01
Bone formation
Lamellar osteoid volume % 16 2.2 5.2 1.0 <0.01
Woven osteoid volume % 5.0 1.4 8.0 1.1 <0.05
Lamellar osteoid surface % 53 3.4 26 3.7 <0.01
Woven ostcoid surface % 12 2.2 28 3.6 <0.01
Bone osteoblast interface % 5.6 1.1 17 2.1 <0.01
Osteoid—osteoblast interface % 8.7 1.8 32 4.0 <0.01
Osteoblastic index 370 72 1173 173 <0.01
# of cells/100 mm boundary length
Peritrabecular fibrosis % 5.6 2.6 28 4.4 <0.01
Bone resorption
Total resorption Iacunae % 7.5 1.1 16 1.7 <0.01
Mineralized bone osteoclast 4,3 0.9 9.3 1.0 <0.05
interface %
Osteoclastic index 89 17 231 27 <0.01
# of cells/lOU mm boundary length
Bone dynamics
Mineral apposition rate p.m/day 0.5 0.07 0.83 0.07 <0.01
Doubly labelled osteoid seams % 5.8 1.8 27 4.3 <0.01
Bone formation rate—trabecular
remodelling unit
(mm3/cm3 X yr) x io 20.6 8.5 98.3 19.6 <0.01
Bone formation rate—osteoblast
level (mm2/cell x yr) x io 0.253 0.10 0.844 0.15 <0.05
calcium and 2 mEq magnesium. Dianeal 137 containing 3.5 mEq
calcium and 1.5 mEq magnesium was used in patients on
chronic ambulatory peritoneal dialysis. None of the patients
were nephrectomized, and subtotal parathyroidectomy was
done in one patient 36 months before the biopsy. No concurrent
therapy was given, with the exception of routine dialysis
support medications such as folic acid, iron, phosphate binders,
and multivitamins.
Bone biopsies
Bone biopsies were taken from the anterior iliac crest in all
patients using an electric drill [14]. Prior to biopsy, all patients
received tetracycline hydrochloride (500 mg p.o. b.i.d.) for two
days; the drug was stopped for ten days and subsequently
demeclocycline hydrochloride (Declomycin® 300 mg p.o. b.i.d.)
was given for four days. Bone biopsies were obtained four days
later. Two bone samples were taken; the first one was obtained
from a point 3 cm behind the anterior superior iliac spine and
the second one at least one centimeter posterior to the first one.
One sample was obtained for mineralized bone histology and
quantitation of stainable aluminum in bone, the second one for
determination of bone aluminum content by atomic absorption
spectrophotometry. Anterior and posterior bone samples were
alternately used for one or the other method of determination of
aluminum in bone.
Mineralized bone histology and histomorphometry of bone
Bone specimens were fixed in ethanol for 24 hours, dehy-
drated and embedded in methylmethacrylate. Serial undecalci-
fled sections of three and seven micrometer thickness were cut
using a Reichert Jung Microtome (Model 1140, Reichert Jung,
Buffalo, New York, USA). Three micrometer thick sections
were stained with the modified Goldner's trichrome stain [15],
which permits discrimination between mineralized and
nonmineralized bone and gives excellent cellular detail [16].
Seven micrometer thick unstained sections were prepared for
phase contrast and fluorescent light microscopy. In addition,
seven micrometer thick sections were stained with the aurin
tricarboxylic acid stain for detection of aluminum [13]. Static
and dynamic parameters of bone structure, bone formation, and
resorption were evaluated using the Osteoplan system accord-
ing to Malluche, et al 117] (Carl Zeiss, Thornwood, New York,
USA). The extent of stainable aluminum deposits was evalu-
ated with the same system and given as a percentage of osteoid
surface as well as trabecular surface exhibiting stainable bone
aluminum at the bone—osteoid interface. A minimum of 50
optical fields were evaluated at a magnification of 200 times
using an objective with 0.4 numerical aperture. All slides were
read without knowledge of clinical and biochemical information
or results of the content of aluminum in bone determined by
atomic absorption spectrophotometry.
Determination of aluminum content in bone
At time of biopsy a cancellous bone sample of approximately
150 mg weight was taken from a standardized site and placed in
an aluminum—free container. Wet bone was prepared as de-
scribed by LeGendre and Alfrey [12]; bone marrow was re-
moved by washing with ajet of deionized water. After drying at
room temperature, the bones were ground in stainless mills
(Perkin—Elmer, Norwalk, Connecticut, USA). The powdered
Stainable aluminum/osteoid surface, %
Fig. 2. Relationship between stainable bone aluminum and lamellar
osteoid volume. (y = —3.26 + 0.33x; r = 0.64;P <0.001).
Stainable aluminum/osteoid surface, %
Results
All patients were found to have histologic signs of renal
osteodystrophy encompassing all known variations [18] that is,
predominant low turnover osteomalacia (N = 6), adynamic
bone disease (N = 3), mixed uremic osteodystrophy consisting
Fig. 3. Relationship between stainable bone aluminum and osteoid—os-
teoblast interface. (y = 26.6 — 0.33x; r = —0.64; P < 0.001).
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bone was then acid digested and aliquots of samples were
analyzed using flameless atomic absorption spectrophotometry
(Perkin—Elmer, Model 5000). For comparison, aluminum con-
tent was determined in anterior iliac—crest bone samples from
40 autopsy cases of the same geographic area as the patients
studied. Determination of aluminum content in bone was done
without knowledge of the histological results.
Statistical analysis
All results are given as mean SEM. Differences were
calculated using the Mann Whitney rank sum test for nonpara-
metric variables. Linear regression analysis and correlations
were calculated between extent of stainable aluminum, bone
aluminum content, and histomorphometric parameters. Corre-
lation coefficients were calculated with correction for repetitive
sampling. All computations were performed with the SPSS
Software Package (Spss, Inc., Chicago, Illinois, USA) using the
IBM-PC Model XT (IBM, Princeton, New Jersey, USA).
of various degrees of hyperparathyroid bone disease and defec-
tive mineralization (N = 30), and predominant hyperparathy-
roid bone disease (N = 16). Stainable bone aluminum at the
mineralization front was found in 26 of the patients studied
(47%). It was seen in all patients with low turnover
osteomalacia or adynamic bone disease and in 17 patients with
mixed uremic osteodystrophy. This was evidenced by a dark
red band at the osteoid—bone interface of at least 10% of the
trabecular surface (Fig. 1). In contrast, bone aluminum content
was above the normal range in all patients (81 9.6 vs. 18 6
jsg/g dry wt).
Differences in static and dynamic histomorphometric param-
eters of bone structure, bone formation, and resorption in
patients with and without stainable bone aluminum are shown
in Table 1. Structural parameters in patients with stainable bone
aluminum displayed lower values of cancellous bone mass,
mean trabecular diameter, and mean wall thickness. In addi-
tion, parameters of bone formation revealed higher volume and
surface of lamellar osteoid and lower volume and surface of
woven osteoid. Cellular parameters of bone formation and
resorption were lower in patients with stainable aluminum as
indicated by lower values of bone—osteoblast interface, lower
number of osteoblasts and osteoclasts, fewer resorption lacu-
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Stainable bone aluminum per osteoid surface and per
trabecular surface correlated with volume of lamellar osteoid
(Fig. 2) and inversely with osteoid—osteoblast interface that is,
the extent of unmineralized trabecular surface covered by
osteoblasts (Fig. 3) as well as with other histomorphometric
cellular parameters of bone formation, such as bone—osteoblast
interface and osteoblastic index (Table 2). In addition, there
was an inverse correlation between stainable bone aluminum
and mineralized bone—osteoclast interface and osteoclastic in-
dex (Fig. 4 and Table 2). Stainable bone aluminum per osteoid
and per trabecular surface also correlated inversely with min-
eral apposition rate and dynamic parameters of bone formation,
such as bone formation rate at the tissue and trabecular
remodelling unit level (Fig. S and Table 2). Bone formation rate
at the cell level correlated with stainable bone aluminum per
osteoid surface only.
In contrast, bone aluminum content correlated with none of
the histomorphometric parameters except lamellar osteoid vol-
ume (Fig. 6).
Stainable bone aluminum given as percentage of trabecular
surface correlated well with stainable aluminum per osteoid
surface (r = 0.92). The correlation between stainable aluminum
per trabecular surface and bone aluminum content was stronger
(r = 0.67) than the one between stainable aluminum per osteoid
surface and bone aluminum content (r = 0.51).
Table 2. Coefficients of correlation between stainable bone
aluminum per osteoid surface (SBA/O), per trabecular surface (SBAI
T), bone aluminum content (BAC) and histomorphometric parameters
of bone
SParameters SBA/O SBA/T BAC
Bone formation
Lamcllar osteoid volume 0.64" —0.80" —0.69"
Bone—osteoblast interface —0.76" —0.17
Osteoid—osteoblast interface —0.64" —0.21
Osteoblastic index —0.64" —0.28
Bone resorption
Mineralized bone—osteoclast interface —0.67" —0.15
Osteoclastic index —0.71" o6o —0.25
Dynamic parametcrs
Mineral apposition rate —0.77" —0.65 —0.20
Bone formation rate—tissue level oss —0.12
Bone formation rate—trabecular —0.75" o54 —0.14
remodelling unit
Bone formation rate—cell level —0.70" —0.35 —0.20
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Fig. S. Relationship between stainable bone aluminum and mineral
apposition rate. ty = 1.21 — 0.0l4x; r = —0.77; P < 0.001).
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Fig. 4. Relationship between stainable bone aluminum and mineral-
ized bone—osteoclast interface. (y = 10.7 — 0.12x; r = —0.82; P <
0.001).
nae and lower mineralized bone—osteoclast interface. Dynamic
parameters disclosed lower mineral apposition rate, less
doubly—labelled osteoid seams, and lower bone formation rates
at the tissue, trabecular remodelling unit, and cell level.
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aluminum and calculated correlations between selected histo-
morphometric parameters of bone and results of bone alumi-
num [5—7, 22—241. A correlation between osteoid volume and
bone aluminum content in trabecular [6] or cortical [5] bone was
found in patients with osteomalacia but not in patients with
predominant hyperparathyroid bone disease. We found a cor-
relation between lamellar osteoid and bone aluminum content
irrespective of the underlying type of bone disease, but no
correlation between woven osteoid and bone aluminum con-
tent. The lack of distinction between woven and lamellar
osteoid in previous reports might explain why there was only a
correlation between bone aluminum content and osteoid vol-
ume in patients with osteomalacia known to have mainly
lamellar osteoid, and not in those with predominant hyperpara-
thyroid bone disease who have accumulation of woven osteoid.
Similarly, stainable bone aluminum was found to correlate with
osteoid volume and ostcoid seam thickness in selected patients
with high bone aluminum content [22]. In a subsequent large
study conducted by the same group [7] no correlation was
reported between stainable bone aluminum and osteoid volume.
This might result from the fact that in one study a small number
•, -, •
of selected patients with osteomalacia was enrolled [221,
• whereas all types of renal bone disease were included in the
• •
' : • later study.
:• •• • Other reports on correlations between stainable bone alumi-
I '- num and histomorphometric parameters describe an inverse
0 50 100 150 200 relationship between stainable bone aluminum and resorption
Bone aluminum content, pg/g dry weight surfaces, fractional labelling of osteoid [23, 24], mineralization
Fig. 6. Relationship between bone aluminum content and lamellar lag time [22, 24], and bone formation rate [24]. Our data are in
osteoid volume. (y = 2.4 + 0.llx; r = 0.59; P < 0.001). agreement with most of the previously published correlations
between stainable bone aluminum and static noncellular
histomorphometric parameters of bone. In this study, we report
Discussion the additional information of a close inverse relationship be-
tween static and dynamic cellular parameters and stainable
Several methods are available for demonstration of accumu- aluminum in bone. Furthermore, we found that there is no such
lation of aluminum in bone. Energy dispersive X-ray analysis correlation between bone aluminum content and cellular param-
[19], analytical ion microscopy [20], and electron probe X-ray eters of bone formation and resorption. These results indicate
microanalysis [21] are sensitive methods but not readily avail- that stainable aluminum in bone is more closely related to
able. They require electron microscopy, which makes it difficult histologic changes in bone than total bone aluminum content. It
and tedious to obtain representative quantitative data. Deter- is of note that the strong correlations between stainable bone
mination of aluminum content by fiameless atomic absorption aluminum at the mineralization front and histopathologic pa-
spectrophotometry represents a well—established and validated rameters of bone do not necessarily establish a cause—and—ef-
procedure [12] which is utilized by an increasing number of fect relationship. The differences in bone turnover of the
laboratories. Stainable bone aluminum is often employed in patients included in our study might affect the localization of
conjunction with histologic evaluation of bone. The extent of aluminum in bone or aluminum localized at the mineralization
aluminum deposits at the bone—osteoid interface can be quan- front might alter, directly or indirectly, the bone turnover. The
titated using principles of histomorphometry [17]. It is apparent in vitro findings of an impaired hydroxyapatite maturation [251
that determination of bone aluminum content reflects the total and of inhibited collagen synthesis by osteoblasts exposed to
amount of aluminum in bone irrespective of its localization extremely high doses of aluminum [26, 27] suggest a direct
within different bone compartments, whereas quantitation of effect of aluminum on osteoblastic function and mineral growth.
stainable bone aluminum gives mainly information on fraction
of osteoid surfaces and/or trabecular surfaces exhibiting alumi-
num deposits. Cournot—Witmer et al [5] reported elevated bone
aluminum content in patients with predominant hyperparathy-
roid bone disease and osteomalacia, but presence of stainable
bone aluminum in patients with osteomalacia only. This is in
agreement with our results and indicates the differences in
distribution of aluminum in bone of renal patients with predom-
inant hyperparathyroid bone disease and osteomalacia. Several
authors measured bone aluminum content or stainable bone
722 Faugere and Malluche
Center, 800 Rose Street, MN 572, Lexington, Kentucky 40536-0084,
USA.
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